Evaluation of the effect of tetravalent (A, C, Y, W-135) meningococcal conjugate vaccine [meningococcal vaccine groups A C Y W-135 conjugate] on serogroup-specific carriage of Neisseria meningitidis
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2007
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Therapeutic Use
- 25 Oct 2006 New trial record.